Oligosynthesis Manufacturing Solutions

Oligonucleotides are one of the most promising therapeutic modalities for today and the future. This class of therapeutics primarily consists of small interfering RNAs (siRNAs), antisense oligonucleotides (ASO), and micro RNAs (miRNAs).

Due to their molecular complexity, oligonucleotides more closely resemble biologics than small molecules; however, their relatively low molecular weight and 16 – 25 mer nucleic acid makeup call for a chemical synthesis approach to manufacturing.

This catalog highlights our suite of solid and liquid handling systems to efficiently produce large-scale oligonucleotides.